AU5135393A - A method of screening compounds and methods for treating alzheimer's disease - Google Patents

A method of screening compounds and methods for treating alzheimer's disease

Info

Publication number
AU5135393A
AU5135393A AU51353/93A AU5135393A AU5135393A AU 5135393 A AU5135393 A AU 5135393A AU 51353/93 A AU51353/93 A AU 51353/93A AU 5135393 A AU5135393 A AU 5135393A AU 5135393 A AU5135393 A AU 5135393A
Authority
AU
Australia
Prior art keywords
disease
methods
treating alzheimer
screening compounds
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51353/93A
Inventor
Trey Sunderland
Benjamin L Wolozin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Army filed Critical US Department of Army
Publication of AU5135393A publication Critical patent/AU5135393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51353/93A 1992-09-21 1993-09-21 A method of screening compounds and methods for treating alzheimer's disease Abandoned AU5135393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94840892A 1992-09-21 1992-09-21
US948408 1992-09-21
PCT/US1993/008969 WO1994007144A1 (en) 1992-09-21 1993-09-21 A method of screening compounds and methods for treating alzheimer's disease

Publications (1)

Publication Number Publication Date
AU5135393A true AU5135393A (en) 1994-04-12

Family

ID=25487803

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51353/93A Abandoned AU5135393A (en) 1992-09-21 1993-09-21 A method of screening compounds and methods for treating alzheimer's disease

Country Status (2)

Country Link
AU (1) AU5135393A (en)
WO (1) WO1994007144A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733524A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
JPH09178743A (en) * 1995-12-27 1997-07-11 Oriental Yeast Co Ltd Determinationof soluble app
WO1998009523A1 (en) * 1996-09-05 1998-03-12 Massachusetts Institute Of Technology Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
US6043283A (en) * 1996-09-20 2000-03-28 Baylor College Of Medicine Tyramine compounds and their neuronal effects
US6071493A (en) * 1996-09-20 2000-06-06 Baylor College Of Medicine Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation
EP1181550A4 (en) * 1999-04-30 2005-03-02 Nathan S Kline Inst For Psychi Methods for the identification of compounds for the treatment of alzheimer's disease
FR2816411B1 (en) 2000-11-03 2003-07-04 Inst Nat Sante Rech Med MEANS FOR DETECTING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND THEIR APPLICATIONS
WO2006043710A1 (en) * 2004-10-19 2006-04-27 Reverse Proteomics Research Institute Co., Ltd. Drug development target protein and target gene, and method of screening

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134062A (en) * 1988-03-22 1992-07-28 Cornell Research Foundation, Inc. Diagnosis of neuronal disorders and screening potential therapeutic agents therefor

Also Published As

Publication number Publication date
WO1994007144A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU2765992A (en) Method for screening for alzheimer's disease
AU4621893A (en) Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
ZA9410095B (en) Methods of inhibiting Alzheimer's Disease
HK1011940A1 (en) A method of treating endo-osteal materials
AU2830097A (en) Therapeutic method for treatment of alzheimer's disease
EP0951293A4 (en) Method for treating alzheimer's disease
AU3597497A (en) Method and apparatus for treating adult-onset dementia of the alzheimer's type
EP0613560A4 (en) A method for assaying and treating alzheimer's disease.
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
IL114466A0 (en) A method for treating and preventing alzheimer's disease
HU906302D0 (en) Process for producing 3'azido-purine-nucleosides and pharmaceutical preparatives containing these compounds
AU5135393A (en) A method of screening compounds and methods for treating alzheimer's disease
AU617252B2 (en) Method of treating tinea
HU9401347D0 (en) Policyclic compounds and process for producing them
AU3915193A (en) Method and apparatus for forming a 360 degree skin handle
AU6973294A (en) Method for treatment of a piece
GB9317920D0 (en) A method of treatment
AU5289590A (en) Method of and means for treating a floor
EP0763143A4 (en) Method of treating titanium parts
AU5102493A (en) A method for the detection and treatment of prostate disease
AU5059896A (en) A method for assaying and treating Alzheimer's disease
HU9300730D0 (en) Protected 4'-demethyl-epypodophyllotoxine-glycoside-4-phosphates and method for producing said compounds
HU9300662D0 (en) Substituted pyridine-sulfonamide compounds and method for producing them
AU7467094A (en) Method of diagnosing alzheimer's disease